The Application of Root Analogy Implant in Immediate Implantation (RAI)

June 6, 2024 updated by: The Dental Hospital of Zhejiang University School of Medicine

A Clinical Exploratory Study of Root Analogy Implant

The current clinical implant techniques used include immediate implantation, early implantation, and delayed implantation. With the acceleration of the current pace of life, immediate implantation is increasingly favored by patients due to its advantages such as fewer surgeries, shorter waiting times, and less impact on aesthetics. The research group has shown that the mismatch between traditional implants and extraction sockets in immediate implantation surgery has caused some complications. Therefore, it is believed that 3D printed personalized root shaped implants with certain roughness are more suitable for use in immediate implantation surgery.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The current clinical implant techniques used include immediate implantation, early implantation, and delayed implantation. With the acceleration of the current pace of life, immediate implantation is increasingly favored by patients due to its advantages such as fewer surgeries, shorter waiting times, and less impact on aesthetics. The research group has shown that the mismatch between traditional implants and extraction sockets in immediate implantation surgery has caused some complications. Therefore, it is believed that 3D printed personalized root shaped implants with certain roughness are more suitable for use in immediate implantation surgery. A 3D printed personalized root implant system jointly developed by Zhejiang University School of Medicine Affiliated Stomatology Hospital, Zhejiang University School of Mechanical Engineering, and Hangzhou Ya Natural Technology Co., Ltd. The implant part of this implant system is implanted into the bone using laser melting printing technology in additive manufacturing methods. The raw material is pure titanium powder, and research results in New Zealand white rabbits and beagles have confirmed that the implant has good bone bonding ability, which can shorten surgical time, reduce surgical frequency, compress implant cycle, restore chewing function, and other advantages. The relevant research results have been published in the top oral journal Journal of Dental Research, and the chemical composition and biological safety of the material have been tested by the Zhejiang Medical Device Inspection and Research Institute (test report number: Z20221903), Z20222527，G20233158）。 The base and other accessories are cut from titanium rods using conventional reduction manufacturing techniques.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
10

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • China
    • Zhejiang
      • Hangzhou, Zhejiang, China, 310006
        • Recruiting
        • The Affiliated Stomatology Hospital, Zhejiang University School of Medicine
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age:20-60 years old, gender unlimited
  • Good oral hygiene
  • No systemic diseases
  • There are irreparable residual roots, no obvious apical periodontitis, no looseness greater than degree II, and the tooth position includes four quadrant anterior teeth and premolars
  • Root length greater than 10 mm, and no significant bone resorption at the alveolar crest
  • There is no significant displacement of adjacent teeth and no significant elongation of opposing teeth
  • The bone density of the target implant area is Class II and Class III
  • The lateral bone wall of the lips (cheeks), palate (tongue) is intact and larger than 1mm
  • The subjects are able to understand the purpose of the experiment, willing to -cooperate with surgical treatment and follow-up, voluntarily participate in the experiment, and sign an informed consent form.

Exclusion Criteria:

  • Patients with moderate to severe periodontitis
  • Missing proximal and distal adjacent teeth in the target residual root
  • Residual roots with root adhesion
  • The target implant area has a bone density of Class I or IV
  • Acute infectious disease or metabolic bone disease activity period
  • Patients with diabetes history and poor blood glucose control (fasting blood glucose ≥ 8.8 mmol/L L)
  • Patients with liver and kidney dysfunction (AST, ALT ≥ 1.5 times ULNULN, creatinine ≥ 1.5 times ULNULN)
  • Individuals with a history of osteoporosis
  • Individuals with a history of malignant tumors or other serious illnesses who are not suitable for surgery
  • Individuals with mental disorders and lack of autonomous behavior ability Pregnant women, lactating or menstruating women, and women with pregnancy plans within six months
  • Various possible causes of imaging artifacts in the surgical area
  • Receiving medication that may affect bone metabolism (such as bisphosphonates) within the past 3 months
  • The researchers estimate poor compliance or other factors that are not suitable for conducting this experiment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: implanted group
This study is a single arm study, with only immediate implantation of root analogy implants
Device: RAI
Immediate implantation

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Alveolar ridge height
Time Frame: day 0,12 weeks,24weeks,48weeks
The distance from the top of the alveolar ridge to the tip of the implant
day 0,12 weeks,24weeks,48weeks

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Width of alveolar ridge, buccal and lingual directions
Time Frame: day 0，12 weeks, 24 weeks, 48 weeks
The width of the implant platform from the buccal and lingual to the alveolar bone
day 0，12 weeks, 24 weeks, 48 weeks
Implant mobility
Time Frame: day 0，12 weeks
Measure the movement of the implant using an implant mobility meter and record the ISQ value
day 0，12 weeks
Gingival condition
Time Frame: day 0, 12 weeks, 24 weeks, 48weeks
Two independent clinical doctors conducted gingival examination in the oral implant area of the patient, and gave a comprehensive score for gingival condition based on changes in gingival color, shape, and texture. A 3-point scoring method was used, with good, average, and poor results.
day 0, 12 weeks, 24 weeks, 48weeks
Exploration depth and Exploring bleeding
Time Frame: 12 weeks, 24 weeks, 48 weeks
Same periodontal probing. Use blunt head periodontal probing to measure the depth of probing at six points around the implant, including the buccal mesial, buccal central, buccal distal, lingual palatal mesial, lingual palatal central, and lingual palatal distal. Record the depth of probing and calculate the average value, 2-4mm if normal, if depth >5mm, consider the occurrence of periimplantitis. The improved gingival sulcus bleeding index (mSBI) can be used to detect bleeding: 0=Along the periphery of the implant, no bleeding after soft tissue edge exploration; 1=scattered points after exploration, hemorrhage in shape; 2=After diagnosis, the bleeding appears linear in the groove; 3=severe or Spontaneous bleeding.
12 weeks, 24 weeks, 48 weeks
Clinical looseness of implants
Time Frame: 12 weeks, 24 weeks, 48 weeks
Evaluation of tooth looseness. Use tweezers to clamp and shake the cutting edge during the examination of anterior dental implants; When checking the posterior dental implant, fold the forceps together and place them in the center of the occlusal fissure, shaking them towards the buccal, lingual (palatal), and mesial and distal directions (clamping the anterior tooth ridge, and pressing the posterior tooth forceps against the posterior occlusal fissure). The commonly used method for recording tooth looseness in clinical practice is to calculate the degree of looseness in millimeters: degree I looseness: the looseness amplitude is within 1mm; Second degree loosening: the loosening amplitude is within 1-2mm; Third degree loosening: the loosening amplitude is above 2mm.
12 weeks, 24 weeks, 48 weeks
Recovery of chewing function
Time Frame: 24 weeks, 48 weeks
The basic method is to use a vernier ruler about 10 cm long, where "0" represents complete dissatisfaction and "10" represents complete satisfaction. The patient marks the line segment based on their own satisfaction, and the physician scores them based on the position marked by the patient.
24 weeks, 48 weeks
Aesthetic satisfaction
Time Frame: 24 weeks，48 weeks
Use a survey questionnaire to evaluate patient satisfaction, including aesthetics and other suggestions and opinions on treatment. The evaluation adopts a 3-point scoring method, which is satisfied, average, and dissatisfied.
24 weeks，48 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
The Dental Hospital of Zhejiang University School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
April 1, 2024

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 31, 2025

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 30, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
May 27, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 6, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 10, 2024

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
June 10, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 6, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
June 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 2024035

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings